Ginger Gregory - Net Worth and Insider Trading
Ginger Gregory Net Worth
The estimated net worth of Ginger Gregory is at least $2 Million dollars as of 2023-03-31. Ginger Gregory is the EVP, Human Resources of Biogen Inc and owns about 5,711 shares of Biogen Inc (BIIB) stock worth over $2 Million. Ginger Gregory is also the Chief Human Resources Officer of Dunkin' Brands Group Inc and owns about 8,500 shares of Dunkin' Brands Group Inc (DNKN) stock worth over $905,080. Details can be seen in Ginger Gregory's Latest Holdings Summary section.
Transaction Summary of Ginger Gregory
Ginger Gregory Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ginger Gregory owns 2 companies in total, including Biogen Inc (BIIB) , and Dunkin' Brands Group Inc (DNKN) .
Click here to see the complete history of Ginger Gregory’s form 4 insider trades.
Insider Ownership Summary of Ginger Gregory
|Ticker||Comapny||Transaction Date||Type of Owner|
|BIIB||Biogen Inc||2017-07-17||EVP & Human Resources|
|DNKN||Dunkin' Brands Group Inc||2013-04-30||Chief Human Resources Officer|
Ginger Gregory Latest Holdings Summary
Ginger Gregory currently owns a total of 2 stocks. Among these stocks, Ginger Gregory owns 5,711 shares of Biogen Inc (BIIB) as of November 14, 2022, with a value of $2 Million and a weighting of 63.45%. Ginger Gregory also owns 8,500 shares of Dunkin' Brands Group Inc (DNKN) as of April 30, 2013, with a value of $905,080 and a weighting of 36.55%.
Latest Holdings of Ginger Gregory
|Ticker||Comapny||Latest Transaction Date||Shares Owned||Current Price ($)||Current Value ($)|
|DNKN||Dunkin' Brands Group Inc||2013-04-30||8,500||106.48||905,080|
Holding Weightings of Ginger Gregory
Ginger Gregory Form 4 Trading Tracker
According to the SEC Form 4 filings, Ginger Gregory has made a total of 1 transactions in Biogen Inc (BIIB) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Biogen Inc is the sale of 5,610 shares on November 14, 2022, which brought Ginger Gregory around $2 Million.
According to the SEC Form 4 filings, Ginger Gregory has made a total of 0 transactions in Dunkin' Brands Group Inc (DNKN) over the past 5 years. The most-recent trade in Dunkin' Brands Group Inc is the sale of 32,500 shares on April 30, 2013, which brought Ginger Gregory around $1 Million.
Insider Trading History of Ginger Gregory
Ginger Gregory Trading Performance
Ginger Gregory Ownership Network
Ownership Network List of Ginger Gregory
Ownership Network Relation of Ginger Gregory
Ginger Gregory Owned Company Details
What does Biogen Inc do?
Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva are marketed via a collaboration with Roche. Biogen also markets novel MS drugs Plegridy, Tysabri, Tecfidera, and Vumerity. In Japan, Biogen's MS portfolio is co-promoted by Eisai. Hemophilia therapies Eloctate and Alprolix (partnered with SOBI) were spun off as part of Bioverativ in 2017. Biogen has several drug candidates in phase 3 trials in neurology and neurodegenerative diseases and has launched Spinraza with partner Ionis. Aduhelm was approved as the firm's first Alzheimer's disease therapy in June 2021, followed by Leqembi in January 2023.
Who are the key executives at Biogen Inc?
Ginger Gregory is the EVP & Human Resources of Biogen Inc. Other key executives at Biogen Inc include Head of Development Priya Singhal , director & President and CEO Christopher Viehbacher , and Head of Pharm Ops and Tech Nicole Murphy .
Biogen Inc (BIIB) Insider Trades Summary
Over the past 18 months, Ginger Gregory made 1 insider transaction in Biogen Inc (BIIB) with a net sale of 5,610. Other recent insider transactions involving Biogen Inc (BIIB) include a net sale of 5,532 shares made by Susan H Alexander ,
In summary, during the past 3 months, insiders sold 0 shares of Biogen Inc (BIIB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 11,142 shares of Biogen Inc (BIIB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 11,142 shares.
Biogen Inc (BIIB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Biogen Inc Insider Transactions
Ginger Gregory Mailing Address
Above is the net worth, insider trading, and ownership report for Ginger Gregory. You might contact Ginger Gregory via mailing address: C/o Biogen Inc., 225 Binney St., Cambridge Ma 02142.